BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18366302)

  • 1. Raman spectroscopy of breast tissues.
    Krishna CM; Kurien J; Mathew S; Rao L; Maheedhar K; Kumar KK; Chowdary MV
    Expert Rev Mol Diagn; 2008 Mar; 8(2):149-66. PubMed ID: 18366302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy.
    Chowdary MV; Kumar KK; Kurien J; Mathew S; Krishna CM
    Biopolymers; 2006 Dec; 83(5):556-69. PubMed ID: 16897764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in noninvasive breast cancer.
    Zhang AH; Sun H; Qiu S; Wang XJ
    Clin Chim Acta; 2013 Sep; 424():3-7. PubMed ID: 23669185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopy and fluorescence photon migration for breast cancer diagnosis and imaging.
    Manoharan R; Shafer K; Perelman L; Wu J; Chen K; Deinum G; Fitzmaurice M; Myles J; Crowe J; Dasari RR; Feld MS
    Photochem Photobiol; 1998 Jan; 67(1):15-22. PubMed ID: 9477761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman spectroscopy can differentiate malignant tumors from normal breast tissue and detect early neoplastic changes in a mouse model.
    Kast RE; Serhatkulu GK; Cao A; Pandya AK; Dai H; Thakur JS; Naik VM; Naik R; Klein MD; Auner GW; Rabah R
    Biopolymers; 2008 Mar; 89(3):235-41. PubMed ID: 18041066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current dilemmas and future perspectives for breast cancer screening with a focus on optimization of magnetic resonance spectroscopic imaging by advances in signal processing.
    Belkic K
    Isr Med Assoc J; 2004 Oct; 6(10):610-8. PubMed ID: 15473589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark.
    Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raman spectroscopy and imaging: applications in human breast cancer diagnosis.
    Brozek-Pluska B; Musial J; Kordek R; Bailo E; Dieing T; Abramczyk H
    Analyst; 2012 Aug; 137(16):3773-80. PubMed ID: 22754917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MRI in screening, diagnosis and management of breast cancer.
    Swayampakula AK; Dillis C; Abraham J
    Expert Rev Anticancer Ther; 2008 May; 8(5):811-7. PubMed ID: 18471052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy.
    Haka AS; Shafer-Peltier KE; Fitzmaurice M; Crowe J; Dasari RR; Feld MS
    Cancer Res; 2002 Sep; 62(18):5375-80. PubMed ID: 12235010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards oncological application of Raman spectroscopy.
    Nijssen A; Koljenović S; Bakker Schut TC; Caspers PJ; Puppels GJ
    J Biophotonics; 2009 Feb; 2(1-2):29-36. PubMed ID: 19343683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raman 'optical biopsy' of human breast cancer.
    Abramczyk H; Brozek-Pluska B; Surmacki J; Jablonska-Gajewicz J; Kordek R
    Prog Biophys Mol Biol; 2012 Jan; 108(1-2):74-81. PubMed ID: 22122914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical correlation of Raman spectra of normal, benign and malignant breast tissues: a spectral deconvolution study.
    Chowdary MV; Kalyan Kumar K; Mathew S; Rao L; Krishna CM; Kurien J
    Biopolymers; 2009 Jul; 91(7):539-46. PubMed ID: 19226625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of breast cancer screening in the world.
    Morimoto T; Nagao T; Okazaki K; Kira M; Nakagawa Y; Tangoku A
    Breast Cancer; 2009; 16(1):2-9. PubMed ID: 18841333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of breast MRI in clinical practice.
    Brennan M; Spillane A; Houssami N
    Aust Fam Physician; 2009 Jul; 38(7):513-9. PubMed ID: 19575070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast self-examination also valuable in women participating in a screening programme].
    Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women at high risk for breast cancer--what the primary care provider needs to know.
    Afonso N
    J Am Board Fam Med; 2009; 22(1):43-50. PubMed ID: 19124632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.